WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017060122) METHODS OF PRESERVING THE BIOLOGICAL ACTIVITY OF RIBONUCLEIC ACIDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/060122    International Application No.:    PCT/EP2016/072927
Publication Date: 13.04.2017 International Filing Date: 27.09.2016
IPC:
A01N 63/02 (2006.01), C12N 15/113 (2010.01), C12N 15/10 (2006.01)
Applicants: SYNGENTA PARTICIPATIONS AG [CH/CH]; Schwarzwaldallee 215 4058 Basel (CH).
DEVGEN NV [BE/BE]; Technologiepark 30 Zwijnaarde 9052 Gent (BE)
Inventors: FELDMANN, Pascale; (BE).
FOWLER, Jeffrey, David; (US).
MADDELEIN, Wendy; (BE).
MAILLET, Isabelle; (BE).
CROMHEECKE, Nina; (BE)
Agent: SYNGENTA INTERNATIONAL AG; Schwarzwaldallee 215 (WRO B8-Z1-30) 4058 Basel (CH)
Priority Data:
62/237,055 05.10.2015 US
Title (EN) METHODS OF PRESERVING THE BIOLOGICAL ACTIVITY OF RIBONUCLEIC ACIDS
(FR) PROCÉDÉS DE PRÉSERVATION DE L'ACTIVITÉ BIOLOGIQUE D'ACIDES RIBONUCLÉIQUES
Abstract: front page image
(EN)The present invention provides a method of substantially retaining or otherwise preserving the biological activity of a dsRNA, present in a cell lysate, to post-transcriptionally silence the expression of a gene in a target organism, comprising the step of adding to the lysate a compound having the function of a protein – or amine - cross linking agent. The invention also comprises compositions comprising the lysate comprising dsRNA, and protein cross linking agents, as well as the use of said agents in the method.
(FR)La présente invention concerne un procédé permettant de retenir ou sinon préserver sensiblement l'activité biologique d'un ARNdb, présent dans un lysat cellulaire, pour inactiver de manière post-transcriptionnelle l'expression d'un gène dans un organisme cible, et comprenant l'étape consistant à ajouter au lysat un composé ayant la fonction d'un agent de réticulation de protéine ou amine. L'invention concerne également des compositions comprenant le lysat incluant l'ARNdb, et des agents de réticulation de protéines, ainsi que l'utilisation desdits agents dans le procédé.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)